ATS
ABBV icon

Ashton Thomas Securities’s AbbVie ABBV Stock Holding History

Ashton Thomas Securities’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.14M Buy
8,610
+3,142
+57% +$676K 0.32% 70
2026
Q1 		$1.19M Buy
5,468
+3,034
+125% +$673K 0.15% 151
2025
Q4 		$556K Sell
2,434
-126
-5% -$28.7K 0.11% 170
2025
Q3 		$592K Buy
2,560
+554
+28% +$113K 0.08% 207
2025
Q2 		$372K Sell
2,006
-192
-9% -$35.7K 0.09% 197
2025
Q1 		$460K Buy
2,198
+116
+6% +$22.6K 0.13% 160
2024
Q4 		$367K Buy
2,082
+140
+7% +$25.7K 0.1% 174
2024
Q3 		$384K Buy
1,942
+344
+22% +$64.2K 0.07% 204
2024
Q2 		$269K Buy
+1,598
New +$265K 0.06% 200

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Ashton Thomas Securities's ABBV Position: Q2 2026 in Review

Ashton Thomas Securities increased its AbbVie (ABBV) stake by 57% in Q2 2026, buying an estimated $676K and bringing the position to 8,610 shares worth $2.14M. The position accounts for 0.32% of the portfolio, ranked #70.

Ashton Thomas Securities first reported a position in ABBV in Q2 2024 and has held it in 9 quarters since. 4,201 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Ashton Thomas Securities held 8,610 shares of AbbVie worth $2.14M as of Q2 2026.
  • Ashton Thomas Securities bought 3,142 AbbVie shares in Q2 2026, an estimated $676K.
  • AbbVie made up 0.32% of Ashton Thomas Securities's portfolio in Q2 2026, its #70 holding.
  • Ashton Thomas Securities first reported a position in AbbVie in Q2 2024 and has held it in 9 quarters since.
  • 4,201 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Ashton Thomas Securities's 13F filing for Q2 2026, filed 27 Jul 2026.